Advertisement

Tricuspid and Pulmonic Valve Pathology

  • Gregory A. FishbeinEmail author
  • Michael C. Fishbein
Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • 14 Downloads
Part of the following topical collections:
  1. Topical Collection on Structural Heart Disease

Abstract

Purpose of Review

This review describes the normal structure and pathologic changes that affect the right-sided cardiac valves and chambers.

Recent Findings

The anatomy and pathology described have been known for many years. Knowledge of these findings has gained relevance. The pattern of endocarditis is changing. New diagnostic techniques have allowed better characterization of lesions responsible for cardiac dysfunction. Novel, less invasive interventions have made recognition of abnormalities more clinically relevant.

Summary

There are many different pathologic entities that can affect the right-sided cardiac valves. These are discussed in this review.

Keywords

Tricuspid valve Pulmonic valve Carcinoid valve disease Regurgitation Stenosis Intravenous drug use Endocarditis Congenital heart disease 

Notes

Compliance with Ethical Standards

Conflict of Interest

Gregory A. Fishbein and Michael C. Fishbein declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Restivo A, Smith A, Wilkinson JL, Anderson RH. The medial papillary muscle complex and its related septomarginal trabeculation. A normal anatomical study on human hearts. J Anat. 1989;163:231–42.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Gould SE, Thomas CC. Pathology of the heart. Springfield: Illinois; 1960.Google Scholar
  3. 3.
    Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation. 2009;119:2726–34.  https://doi.org/10.1161/CIRCULATIONAHA.108.776021.CrossRefPubMedGoogle Scholar
  4. 4.
    Tede NH, Shivkumar K, Perloff JK, Middlekauff HR, Fishbein MC, Child JS, et al. Signal-averaged electrocardiogram in Ebstein’s anomaly. Am J Cardiol. 2004;93:432–6.  https://doi.org/10.1016/j.amjcard.2003.10.058.CrossRefPubMedGoogle Scholar
  5. 5.
    Emmanoulides GC, Thanopoulos B, Siassi B, Fishbein M. “Agenesis” of ductus arteriosus associated with the syndrome of tetralogy of Fallot and absent pulmonary valve. Am J Cardiol. 1976;37:403–9.CrossRefGoogle Scholar
  6. 6.
    Altrichter PM, Olson LJ, Edwards WD, Puga FJ, Danielson GK. Surgical pathology of the pulmonary valve: a study of 116 cases spanning 15 years. Mayo Clin Proc. 1989;64:1352–60.CrossRefGoogle Scholar
  7. 7.
    Hurwitz LE, Roberts WC. Quadricuspid semilunar valve. Am J Cardiol. 1973;31:623–6.CrossRefGoogle Scholar
  8. 8.
    Castonguay MC, Burner KD, Edwards WD, Baddour LM, Maleszewski JJ. Surgical pathology of native valve endocarditis in 310 specimens from 287 patients (1985-2004). Cardiovasc Pathol. 2013;22:19–27.  https://doi.org/10.1016/j.carpath.2012.05.007.CrossRefGoogle Scholar
  9. 9.
    • Yuan SM. Right-sided infective endocarditis: recent epidemiologic changes. Int J Clin Exp Med 2014;7:199–218. This study provides a contemporary review of the risk factors and pathologic features of endocarditis specifically involving the right side of the heart. Google Scholar
  10. 10.
    Pellicelli AM, Pino P, Terranova A, D’Ambrosio C, Soccorsi F. Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature. Cardiovasc Ultrasound. 2005;3:30.  https://doi.org/10.1186/1476-7120-3-30.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155:1641–8.  https://doi.org/10.1001/archinte.1995.00430150125013.CrossRefPubMedGoogle Scholar
  12. 12.
    Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. Prospective study of infective endocarditis among injection drug users. J InfectDis. 2002;185:1761–6.CrossRefGoogle Scholar
  13. 13.
    Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis. 2012;31:2905–10.  https://doi.org/10.1007/s10096-012-1675-x.CrossRefPubMedGoogle Scholar
  14. 14.
    Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis. 1992;15:910–23.CrossRefGoogle Scholar
  15. 15.
    Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am. 2002;16:273–95 vii–viii.CrossRefGoogle Scholar
  16. 16.
    Delaney KA. Endocarditis in the emergency department. Ann Emerg Med. 1991;20:405–14.  https://doi.org/10.1016/S0196-0644(05)81663.-4.CrossRefPubMedGoogle Scholar
  17. 17.
    • Bhattacharyya S, Davar J, Dreyfus G, Caplin ME. Carcinoid heart disease. Circulation. 2007;116:2860–5.  https://doi.org/10.1161/CIRCULATIONAHA.107.701367 This paper provides an in-depth overview of the pathogenesis and clinicopathologic features of carcinoid heart disease, including diagnostic modalities and treatment strategies. CrossRefGoogle Scholar
  18. 18.
    Wilkowske MA, Hartmann LC, Mullany CJ, Behrenbeck T, Kvols LK. Progressive carcinoid heart disease after resection of primary ovarian carcinoid. Cancer. 1994;73:1889–91.CrossRefGoogle Scholar
  19. 19.
    Roberts WC. A unique heart disease associated with a unique cancer: carcinoid heart disease. Am J Cardiol. 1997;80:251–6.CrossRefGoogle Scholar
  20. 20.
    Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79:339–54.CrossRefGoogle Scholar
  21. 21.
    Fishbein MC, Tan KS, Beazell JW, Schulman JH, Hirose FM, Criley JM. Cardiac pathology of transvenous pacemakers in dogs. Am Heart J. 1977;93:73–81.CrossRefGoogle Scholar
  22. 22.
    Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349–55.  https://doi.org/10.1161/CIRCULATIONAHA.106.678664.CrossRefPubMedGoogle Scholar
  23. 23.
    Wong RC-C, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R, et al. Tricuspid regurgitation after cardiac transplantation: an old problem revisited. J Heart Lung Transplant. 2008;27:247–52.  https://doi.org/10.1016/j.healun.2007.12.011.CrossRefPubMedGoogle Scholar
  24. 24.
    Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766–73.  https://doi.org/10.1016/S0046-8177(96)90447-5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations